AMFI - Registered Mutual Fund Distributor

Curis Lifesciences Limited IPO

Curis Lifesciences Limited IPO

₹ 256000 / 2000 Shares Shares
Minimum Investment

Curis Lifesciences Limited IPO

Issues Price

₹120-128 per equity share

Curis Lifesciences Limited IPO

Open Date

07 Nov 2025

Close Date

11 Nov 2025

Lot Size

1000

Min. Investment

₹ 256000

Issue Price

₹120-128

Listing Date

14 Nov 2025

Issues Size

21,50,000 shares(aggregating up to ₹27.52 crore)

Face Value

₹10 Per Equity Share

Total Shares Offered

2000 Shares

Offered To Public

2000 Shares

Curis Lifesciences Limited IPO

Established in 2010, Curis Lifesciences Limited is a pharmaceutical company specializing in the development, manufacturing, and distribution of a diverse range of products. The company manufactures pharmaceutical products both internationally and nationally on a loan license or on a contract basis, and for own brand marketing.The company serves over 100 corporate clients on loan licenses or contract manufacturing and 2 clients for its own brand marketing in Yemen and Kenya. Curis Lifesciences specializes in the development, manufacturing, and distribution of a broad array of pharmaceutical products that include: General pharmaceutical tablets and capsules Oral liquids External preparations Sterile ophthalmic ointments The firm has a state-of-the-art manufacturing facility in Sanand, Gujarat, operating under strict quality control measures to ensure the safety and efficacy of its products.The company offers different pharmaceutical formulations and products made on a contract basis.They provide tablets, capsules, external preparations, oral liquids, and sterile ophthalmic ointments. As of June 30, 2024, the company has 93 permanent employees.

Founded In

2020

Managing Director

Dharmesh Dasharathbhai Patel

Parent Organization

Curis Lifesciences Limited IPO

Application for Curis Lifesciences Limited IPO

Apply as Price Range Apply Upto
Individual (min) ₹120-128 ₹2,56,000
Individual(max) ₹120-128 ₹2,56,000
SHNI(min) ₹120-128 ₹3,84,000
SHNI(max) ₹120-128 ₹8,96,000
BHNI(min) ₹120-128 ₹10,24,000

Apply for all eligible candidates, Curis Lifesciences Limited IPO.

ksquare

Open On12 Dec 2025

Close On16 Dec 2025

Price Range₹2061-2165

ksquare

Open On15 Dec 2025

Close On17 Dec 2025

Price Range₹126

ksquare

Open On12 Dec 2025

Close On16 Dec 2025

Price Range₹135-142

ksquare

Open On11 Dec 2025

Close On15 Dec 2025

Price Range₹94-96

ksquare

Open On11 Dec 2025

Close On15 Dec 2025

Price Range₹112-118

ksquare

Open On10 Dec 2025

Close On12 Dec 2025

Price Range₹12


Testimonial

Genuine Review Form Statisifed Customers

4.9 Out of 5 (5239 Reviews)

I was skeptical about loans on mutual funds, but KSquare provided full clarity and fast execution. Loved the experience!

Ishita Mehra

Ishita Mehra

Research Associate

Investing in NFOs through KSquare has been a game changer. Their platform simplifies complex information and provides well-timed suggestions that fit my portfolio.

Rohan Mittal

Rohan Mittal

Financial Auditor

I highly recommend KSquare for any NRI investor. Their support was proactive and always ensured I felt secure with every transaction.

Arjun Mehra

Arjun Mehra

Cybersecurity Expert

KSquare gave me clarity in my mutual fund journey. I now know where my money goes and how it grows. Their dashboard is excellent.

Harshit Chawla

Harshit Chawla

Insurance Advisor

KSquare offered everything I needed to invest from the UK. Their NRI Corner is efficient, clear, and built with trust.

Rhea Menon

Rhea Menon

Fashion Designer

I’m impressed by how easy KSquare made mutual fund investing. Their platform is clean, quick, and their support staff is always ready to help.

Reena Saxena

Reena Saxena

Art Teacher

I needed urgent cash flow and didn’t want to redeem my funds. KSquare had the perfect solution. Very helpful service!

Karan Duggal

Karan Duggal

Creative Producer

I use KSquare to manage my NRI investments. They provide clarity, legal compliance, and reliable support every step of the way. Excellent platform!

Siddharth Jain

Siddharth Jain

Business Owner

I didn’t want to disturb my investments, and KSquare gave me the perfect option. I got the loan in no time.

Nikhil Rane

Nikhil Rane

Visual Designer

Mutual funds were new to me, but KSquare’s team made sure I understood everything. I now invest regularly with confidence and clarity.

Tanvi Desai

Tanvi Desai

Nutrition Consultant

FAQ's

Frequenlty Asked Question

Is there a lock-in period for mutual fund investments?

Only ELSS funds have a 3-year lock-in. Other funds generally allow you to redeem anytime based on NAV.

How are mutual fund returns calculated?

Returns are based on the Net Asset Value (NAV) movement of the fund and any dividends paid out over time.

Can NRIs invest in NFOs via KSquare?

Yes, most NFOs are open to NRIs subject to fund house guidelines. KSquare helps confirm eligibility for NRIs.

What if I fail to repay the loan on time?

In case of default, the lender may sell pledged mutual fund units. KSquare advises timely repayment to avoid any financial impact.

What documents are required to invest in mutual funds via KSquare?

You need a PAN card, Aadhaar, bank details, and address proof for KYC verification before starting investments.

Can I track my SIP performance on KSquare?

Yes, KSquare offers detailed tracking tools and insights so you can monitor your SIP performance anytime.

Are NFOs better suited for long-term investors?

NFOs are ideal for long-term investors who can wait for the fund to build performance and portfolio over time.

What services does KSquare offer for NRIs in India?

KSquare provides investment solutions, tax planning, mutual funds access, and portfolio management tailored specifically for NRIs.

App Store